Clinatec's ECoG decoder drives a four-limb exoskeleton

A 28-year-old with C4-C5 tetraplegia cortically controlled simulated walking and 8-DoF arm movements over 24 months (Lancet Neurology 2019).

21ⓘ

AI system

System

Clinatec epidural wireless brain-machine interface with adaptive decoder driving a four-limb exoskeleton and virtual avatar

Model

Not assessed

Release

Not assessed

Application developer

CEA-Clinatec (public research institute, not a company) with Grenoble University Hospital

Role

Not assessed

Configuration

Not assessed

Inputs and outputs

Not assessed

Autonomy

Not assessed

Workflow

Chronic bilateral epidural ECoG recorders with wireless transmission. Adaptive, incrementally trained decoder with idle-state support. Progressive training on mental tasks over 24 months.

Human oversight

Not assessed

Relation to AI

The adaptive decoding algorithm converts epidural ECoG into effector commands. The same group later described it as a recursive exponentially weighted Markov-switching multilinear mixture-of-experts model. Without it the implants record only. The exoskeleton itself was ceiling-suspended in the laboratory.

AI contribution

The adaptive decoding algorithm converts epidural ECoG into effector commands. The same group later described it as a recursive exponentially weighted Markov-switching multilinear mixture-of-experts model. Without it the implants record only. The exoskeleton itself was ceiling-suspended in the laboratory.

Benefits

Outcome identifiers

Not assessed

Benefit

64.0% success using the avatar at home and 70.9% with the exoskeleton in the laboratory

Category

Improved Accessibility

Status

Not assessed

Beneficiary groups

People. Society.

Beneficiaries

Not assessed

Reach

Not assessed

Distribution and access

Not assessed

Duration

Not assessed

Expected?

Yes

Costs and harms

Not assessed

Measurement

Studies

Not assessed

Study design

Not assessed

Measurement

Not assessed

Setting and sample

Not assessed

Measures

64.0% success using the avatar at home and 70.9% with the exoskeleton in the laboratory

Comparison

Not assessed

Results

64.0% success using the avatar at home and 70.9% with the exoskeleton in the laboratory

Additional value from AI

Not assessed

Limitations

Not assessed

Denominators

Not assessed

Materials for replication

Not assessed

Money

Kind of value

Not assessed

Amount

Not assessed

Currency and prices

Not assessed

Period and unit

Not assessed

Realization

Not assessed

Recipients and payers

Not assessed

Gross or net

Not assessed

Included costs

Not assessed

Comparison

Not assessed

Method

Not assessed

Return and payback

Not assessed

People and places

Participants

Developer: CEA-Clinatec (public research institute, not a company) with Grenoble University Hospital. Operator: Clinatec research center / Grenoble University Hospital clinical trial.

Jurisdictions

Benefit: Grenoble, France. Developer: France. Operator: France.

Ownership and control

Not assessed

Dependencies

Not assessed

Cross-border connections

Not assessed

Geopolitical implications

Not assessed

Follow-up

Conditions for replication

Stable epidural signal quality over years. Decoder recalibration roughly every seven weeks. Laboratory suspension system for safe exoskeleton walking.

Replication attempts

1 follow-up entries. Benefit recurred: 1.

Later findings

30 March 2022. The same patient was still controlling the exoskeleton bimanually more than three years after implantation, with a decoder stable for six months without recalibration.

Availability

Not assessed

Institutional decision

Not assessed

Grounds

Not assessed

Action and result

Not assessed

Success criterion

Not assessed

Evidence

Source numbers

AIBD-0053-source-0001–0003

Citations

Numbered references below.

Language

Not assessed

Source relationships

Developer

Original evidence

Not assessed

Access and versions

Not assessed

Supported findings

Not assessed

Evidence strength

Not assessed

Missing evidence

Not assessed

Grades

Assessed benefits

People. Society.

Depth

People: 2. Society: 1.

Reasons

People: One identifiable participant gained brain-controlled walking simulation and eight-degree-of-freedom arm control, exercised at home with an avatar and in the lab with the exoskeleton. It did not yet provide everyday mobility. Society: Single-patient proof of concept for semi-invasive long-term BCI. No population effect.

Observed or intended

Not assessed

Rubric

Not assessed

Assessor and date

Not assessed

Alternative assessments

Not assessed

Fill

The makers' claim

Entry details

Kind

Not assessed

Field

Neurotechnology / mobility rehabilitation. People with tetraplegia.

Purpose

Restore mobility to people with tetraplegia by decoding brain signals to drive an exoskeleton

Dates

Date basis unassessed: 2017 (precision unassessed). Updated: 21 October 2026.

Stage

Not assessed

Version

SHA-256: c81e4df8b066…

References

Other identifiers

Not assessed

Category mappings

Not assessed

Brief

Not assessed

Revisions

4 revisions. Latest: 21 October 2026.

Sources

  1. Peer-reviewed study Developer

    Benabid AL, Costecalde T, Eliseyev A, et al. (2019). An exoskeleton controlled by an epidural wireless brain-machine interface in a tetraplegic patient: a proof-of-concept demonstration. Lancet Neurology 18(12):1112-1122.

  2. Peer-reviewed study Developer

    Moly A, Costecalde T, Martel F, et al. (2022). An adaptive closed-loop ECoG decoder for long-term and stable bimanual control of an exoskeleton by a tetraplegic. Journal of Neural Engineering 19(2).